Markets
Tech
Media
Success
Video
Markets
Premarkets
Dow
After-Hours
Market Movers
Fear & Greed
World Markets
Investing
Markets Now
Before the Bell
Leading Indicator
Global Energy Challenge
Economy
Energy
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Business Evolved
Work Transformed
Innovative Cities
Unhackable
Media
Reliable Sources
Success
Boss Files
Fresh Money
Cars
Homes
Biz + Leisure
Center Piece
Perspectives
Video
International
Switzerland
India
Davos
Passion to Portfolio
On: Germany
More
Newsletters
About Us
Accessibility and CC
U.S.
World
Politics
Business
Opinion
Health
Entertainment
Tech
Style
Travel
Sports
Video
Shop
VR
More...
Follow CNN Business
Do Not Sell
Amgen Inc
(NASDAQ:AMGN)
271.31
Delayed Data
As of Dec 07
+1.96
/
+0.73%
Today’s Change
211.71
Today
|||
52-Week Range
288.46
+3.30%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Latest AMGN News
|
Press Releases
Amgen (AMGN) Registers a Bigger Fall Than the Market: Important Facts to Note
Dec 06 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights McDonald's, Amgen, NextEra Energy, General Mills and Take-Two Interactive Software
Nov 30 / Zacks.com - Paid Partner Content
Amgen: Relative Valuation Remains Unattractive
Dec 06 / GuruFocus News - Paid Partner Content
Amazon (AMZN) Teams Up With Amgen, Expands Customer Base
Nov 30 / Zacks.com - Paid Partner Content
3 Top Dividend Stocks to Maximize Your Retirement Income
Dec 04 / Zacks.com - Paid Partner Content
Top Stock Reports for McDonald's, Amgen & NextEra Energy
Nov 29 / Zacks.com - Paid Partner Content
3 Top Dividend Stocks to Maximize Your Retirement Income
Dec 04 / Zacks.com - Paid Partner Content
Is Trending Stock Amgen Inc. (AMGN) a Buy Now?
Nov 28 / Zacks.com - Paid Partner Content
Pfizer (PFE) Stock Down 5% as Obesity Drug Fails in Phase II
Dec 04 / Zacks.com - Paid Partner Content
1 Spectacular Dividend Stock Every Investor Should Consider
Nov 28 / MotleyFool.com - Paid Partner Content
Why Is BioMarin (BMRN) Up 14.3% Since Last Earnings Report?
Dec 01 / Zacks.com - Paid Partner Content
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Nov 28 / Zacks.com - Paid Partner Content
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Dec 01 / Zacks.com - Paid Partner Content
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
Nov 27 / Zacks.com - Paid Partner Content
Amgen (AMGN) Up 2.2% Since Last Earnings Report: Can It Continue?
Nov 30 / Zacks.com - Paid Partner Content